Across the country, state lawmakers are considering ways to address the risks posed by the explosion of power-hungry data ...
In this week’s Crypto Long & Short Newsletter, Ruchir Gupta writes on how we’re moving toward a true fixed-income market for ...
Kyntra Bio, Inc. (NASDAQ:KYNB) Q4 2025 Earnings Call Transcript March 16, 2026 Kyntra Bio, Inc. beats earnings expectations. Reported EPS is $-3.61, expectations were $-3.885. Operator: Thank you for ...
Lens AI, powered by the proprietary HIFT system, advanced functional adjacency capabilities and identified a single conserved functional feature across 2,000+ influenza sequences. Dengue Pipeline -- ...
The literature on physician-mediated interventions to reduce costs is scant and provides little guidance on effective ...
Kyntra Bio(NASDAQ:KYNB) reported that its rebranding, asset sale, and debt payoff have shifted the company’s financial structure and enabled a clinical focus on oncology and rare disease. Management ...
Third-party apps, aftermarket parts, and hidden settings can make your Peloton experience so much better.
Dividend Declaration -- The Board declared a $0.42 per share dividend, representing a 9.8% annualized rate on ending book ...
Total revenue -- $41.3 million in fiscal Q4 (period ended Dec. 31, 2025), with $25.3 million from Energy Industrial and $16.1 ...
Good afternoon, and welcome to Arthur J. Gallagher & Company's quarterly investor meeting with management. [Operator Instructions] Today's call is being recorded. If you have any objections, you may ...
Q4 2025 Earnings Call March 4, 2026 5:00 PM ESTCompany ParticipantsKyle Pilkington - Chief Legal OfficerQichao Hu - ...
Thank you, Jonathan, and thanks to all of you for joining us this afternoon to review Definitive Healthcare Corp.'s fourth ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results